文献速递焦虑、强迫与应激相关障碍

杏仁核GluA1水平与前海马GluA1-Ser845磷酸化是发作性恐惧而非焦虑的生物标志物

Amygdala levels of the GluA1 subunit of glutamate receptors and its phosphorylation state at serine 845 in the anterior hippocampus are biomarkers of ictal fear but not anxiety.
PubMed 文献 · Mol Psychiatry · 2018-06-07

该研究用免疫印迹法检测伴海马硬化内侧颞叶癫痫患者杏仁核、前海马及颞新皮质中GluA1及其Ser845/Ser831磷酸化水平,比较有发作性恐惧(n=6)与无发作性恐惧(n=25)患者的差异,发现前者杏仁核GluA1降低11%(p=0.05)、前海马P-GluA1-Ser845降低21.5%(p=0.009),联合预测发作性恐惧的总体准确率为89.3%,这些指标与精神科诊断和症状无关。

要点

  • 发作性恐惧患者杏仁核GluA1较无发作性恐惧者降低11%(p=0.05)。
  • 发作性恐惧患者前海马P-GluA1-Ser845降低21.5%(p=0.009)。
  • 杏仁核GluA1与前海马P-GluA1-Ser845联合预测发作性恐惧的总体准确率为89.3%。

核心结论

  • 杏仁核GluA1水平降低和前海马P-GluA1-Ser845水平降低是伴海马硬化内侧颞叶癫痫患者发作性恐惧而非焦虑的生物标志物。
  • 杏仁核GluA1与前海马P-GluA1-Ser845联合预测发作性恐惧的总体准确率为89.3%(特异性95.5%,敏感性66.7%)。
  • 杏仁核GluA1水平与前海马P-GluA1-Ser845水平与患者的精神科诊断和症状无关。

研究设计与样本

  • 研究纳入伴海马硬化的内侧颞叶癫痫患者,按有无发作性恐惧分为有发作性恐惧组(n=6)和无发作性恐惧组(n=25)。
  • 采用免疫印迹法测定杏仁核、前海马和颞新皮质中GluA1水平及Ser845、Ser831位点磷酸化水平。

主要发现

  • 有发作性恐惧患者杏仁核GluA1水平较无发作性恐惧患者降低11%(p=0.05)。
  • 有发作性恐惧患者前海马P-GluA1-Ser845水平较无发作性恐惧患者降低21.5%(p=0.009)。
  • 上述关联与其他先兆类型分布、人口学、临床或神经外科变量无关。
  • 前海马P-GluA1-Ser845降低与PP1-alpha催化亚基水平或蛋白激酶A激活变化无关。
  • 杏仁核GluA1与前海马P-GluA1-Ser845联合预测发作性恐惧的总体准确率为89.3%(特异性95.5%,敏感性66.7%)。

关键数值与推荐

  • 有发作性恐惧组(n=6)杏仁核GluA1水平较无发作性恐惧组(n=25)降低11%(p=0.05)。
  • 有发作性恐惧组前海马P-GluA1-Ser845水平较无发作性恐惧组降低21.5%(p=0.009)。
  • 杏仁核GluA1与前海马P-GluA1-Ser845联合预测发作性恐惧的总体准确率为89.3%(特异性95.5%,敏感性66.7%)。

临床怎么用

  • 在伴海马硬化的内侧颞叶癫痫患者中,杏仁核GluA1和前海马P-GluA1-Ser845水平有望作为发作性恐惧的生物标志物。
  • 这些标志物与精神科诊断和症状无关,提示其识别的是发作性恐惧而非焦虑。

局限性

  • 有发作性恐惧组样本量仅6例,结果需更大样本验证。
  • 研究为横断面设计,无法确定GluA1水平变化与发作性恐惧的因果关系。
  • 研究仅纳入伴海马硬化的内侧颞叶癫痫患者,结论外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Fear is a conscious state caused by exposure to real or imagined threats that trigger stress responses that affect the body and brain, particularly limbic structures. A sub-group of patients with mesial temporal lobe epilepsy related to hippocampus sclerosis (MTLE-HS) have seizures with fear, which is called ictal fear (IF), due to epileptic activity within the brain defensive survival circuit structures. Synaptic transmission efficacy can be bi-directionally modified through potentiation (long-term potentiation (LTP)) or depression (long-term depression (LTD)) as well as the phosphorylation state of Ser831 and Ser845 sites at the GluA1 subunit of the glutamate AMPA receptors, which has been characterized as a critical event for this synaptic plasticity. In this study, GluA1 levels and the phosphorylation at Ser845 and Ser831 in the amygdala (AMY), anterior hippocampus (aHIP) and middle gyrus of temporal neocortex (CX) were determined with western blots and compared between MTLE-HS patients who were showing (n = 06) or not showing (n = 25) IF. Patients with IF had an 11% decrease of AMY levels of the GluA1 subunit (p = 0.05) and a 21.5% decrease of aHIP levels of P-GluA1-Ser845 (p = 0.009) compared to patients not showing IF. The observed associations were not related to imbalances in the distribution of other concomitant types of aura, demographic, clinical or neurosurgical variables. The lower levels of P-GluA1-Ser845 in the aHIP of patients with IF were not related to changes in the levels of the serine/threonine-protein phosphatase PP1-alpha catalytic subunit or protein kinase A activation. Taken together, the GluA1 subunit levels in AMY and P-GluA1-Ser845 levels in the aHIP show an overall accuracy of 89.3% (specificity 95.5% and sensitivity 66.7%) to predict the presence of IF. AMY levels of the GluA1 subunit and aHIP levels of P-GluA1-Ser845 were not associated with the psychiatric diagnosis and symptoms of patients. Taken together with previous findings in MTLE-HS patients with IF who were evaluated by stereotactic implanted depth electrodes, we speculate our findings are consistent with the hypothesis that AMY is not a centre of fear but together with other sub-cortical and cortical structures integrates the defensive circuit that detect and respond to threats. This is the first report to address neuroplasticity features in human limbic structures connected to the defensive survival circuits, which has implications for the comprehension of highly prevalent psychiatric disorders and symptoms.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Leal RB, Lopes MW, Formolo DA, et al. Amygdala levels of the GluA1 subunit of glutamate receptors and its phosphorylation state at serine 845 in the anterior hippocampus are biomarkers of ictal fear but not anxiety. Mol Psychiatry. 2018. PMID: 29880883. doi:10.1038/s41380-018-0084-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。